New Oncology opportunity It sure seems that some people are missing the point of the news release.
New drug/treatment opportunities by targetting the lymphatic system
The test was done on non sick/cancerous subjects to see where the drug goes when no target is present
The opportunities from this finding are of such importance that they had to wait for pattents to be filled before informing investors and scientists
“The xB3-001 lymphatic and lymph node penetration observed in the current study supports the utility of the xB3 platform for many CNS and non-CNS disorders,” said Mario Saltarelli, M.D., Ph.D., Bioasis SAB member; former executive vice president and chief medical officer, Syntimmune
"The lymphatic system is an important target for developing new vaccines, cancer treatments and diagnostic agents. For example, most solid cancers initially spread from the primary site via the tumor’s surrounding lymphatics before hematological dissemination"
To recap, this is huge news because it shows that the xb3 peptide is not only great at targetting the brain, but opens up a huge opportunity in cancer treatment. We should also remember that metastasis of many cancers happens through the lymphatic system and if we are able to target while in transit before metasis is complete, that could be a total game changer in oncology!